Status:
COMPLETED
Menopause is a Critical Factor in Determining Failure of Antiviral Therapy in Women With Chronic Hepatitis C
Lead Sponsor:
Prof. Facchinetti Fabio
Collaborating Sponsors:
Merck Sharp & Dohme LLC
Conditions:
Chronic Hepatitis C
Eligibility:
All Genders
18-75 years
Brief Summary
Menopause represents a critical period in a woman's life as the hormonal changes and the failing ovarian function not only determine relevant modifications in the reproductive function but also in man...
Detailed Description
The study is designed retrospective epidemiological cohort study. Overall, a group of 442 women (168 still in fertile age; 274 menopausal) with HCV-positive CAH who underwent PEG IFN treatment in the ...
Eligibility Criteria
Inclusion
- All women treated for HCV chronic hepatitis, at the Unit Gastroenterology, University of Modena and Reggio Emilia, in the last 7 years.
- Control group is a cohort matched for age (ratio 1:1) selected from a group of 558 men with chronic HCV treated in the same period
Exclusion
- No exclusion criteria aret pre-defined as the study includes all patients who were treated for chronic HCV hepatitis; exclusion was made upstream of the constitution of this cohort.
Key Trial Info
Start Date :
July 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2011
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT01402583
Start Date
July 1 2011
End Date
September 1 2011
Last Update
October 21 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Gastroenterology Unit
Modena, Italy, 41124